Weekly News Recap #Phispers
FDA approves Ozempic to treat CKD in diabetes patients; AbbVie, Neomorph ink US$ 1.64 bn deal for molecular glue degraders
Novo Nordisk’s Ozempic became the first glucagon-like peptide 1 (GLP-1) drug to receive the US Food and Drug Administrati...
Impressions : 1323
Trump withdraws US from WHO; Novo’s Ozempic, Wegovy among 15 new drugs chosen for price negotiations under IRA
On the day Donald Trump was sworn in as the 47th President of the United States, there was a deluge of some 200 measures, which...
Impressions : 1889
Sanofi and AbbVie CEOs suffer pay cuts, FDA Warning Letters to Pfizer, Jubilant’s Indian operations
This week, Phispers brings you news about two antidepressants — J&J’s esketamine and Allergan’s rapastine...
Impressions : 3603
2017 closes with record approvals of generics, novel drugs; 2018 begins with reprieves for Teva
PharmaCompass wishes its readers a very happy new year. We begin the year with an analysis of 2017, when we saw record approval...
Impressions : 4358
- Privacy policy
- Terms and conditions
- Disclaimers
-
- Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.